Blog: Apr 2021

Oxford-AstraZeneca vaccine: Under 30 and live with someone with MS?

9 April 2021

Source MS Society: Following the recent announcement about the Oxford-AstraZeneca vaccine: The news might affect you if you're under 30 and you live with someone with MS.

Ofatumumab licensed for active relapsing-remitting MS in UK

9 April 2021

Source MS Society: The Medicines and Healthcare products Regulatory Agency (MHRA), and European Commission (EC) have licenced ofatumumab to treat adults with active relapsing MS.

Donations to the Centre

9 April 2021

We need your help, will you donate today?